The microanatomy of spinal cord injury: A review

Clinical Anatomy

Volumn 28, Issue 1, 2015, Pages 27-36

  Mortazavi, Martin M ^a   Verma, Ketan ^b   Harmon, Olivia A ^b   Griessenauer, Christoph J ^b   Adeeb, Nimer ^b   Theodore, Nicholas ^c   Tubbs, R Shane ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Pediatric Neurosurgery   (United States)

^c Barrow Neurological Institute   (United States)

Author keywords

compromise; inflammation; injury; mechanisms; spinal cord; therapy; vascular

Indexed keywords

MANNITOL;

ANATOMY; AUTOREGULATION; HUMAN; INFLAMMATION; INFLAMMATORY CELL; ISCHEMIA; MICROANATOMY; NEUROPROTECTION; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; SPINAL CORD INJURY; CEREBROSPINAL FLUID PRESSURE; EVOKED RESPONSE; HOMEOSTASIS; IMMUNOLOGY; METABOLISM; PATHOLOGY; SPINAL CORD; SPINAL CORD COMPRESSION; SPINAL CORD INJURIES; VASCULARIZATION;

CEREBROSPINAL FLUID PRESSURE; EVOKED POTENTIALS; HOMEOSTASIS; HUMANS; INFLAMMATION; ISCHEMIA; SPINAL CORD; SPINAL CORD COMPRESSION; SPINAL CORD INJURIES;

EID: 84916882337     PISSN: 08973806     EISSN: 10982353     Source Type: Journal    
DOI: 10.1002/ca.22432     Document Type: Review

References (112)

1. Amar AP, Levy ML,. 1999. Pathogenesis and pharmacological strategies for mitigating secondary damage in acute spinal cord injury. Neurosurgery 44: 1027-1039; discussion 1039-1040.
2. Anderson AJ, Robert S, Huang W, Young W, Cotman CW,. 2004. Activation of complement pathways after contusion-induced spinal cord injury. J Neurotrauma 21: 1831-1846.
3. Ankeny DP, Popovich PG,. 2009. Mechanisms and implications of adaptive immune responses after traumatic spinal cord injury. Neuroscience 158: 1112-1121.
4. Ankeny DP, Lucin KM, Sanders VM, McGaughy VM, Popovich PG,. 2006. Spinal cord injury triggers systemic autoimmunity: Evidence for chronic B lymphocyte activation and lupus-like autoantibody synthesis. J Neurochem 99: 1073-1087.
5. Banati RB, Gehrmann J, Schubert P, Kreutzberg GW,. 1993. Cytotoxicity of microglia. Glia 7: 111-118.
6. Basu A, Krady JK, Levison SW,. 2004. Interleukin-1: A master regulator of neuroinflammation. J Neurosci Res 78: 151-156.
7. Baysefer A, Erdogan E, Kahraman S, Izci Y, Korkmaz C, Solmaz I, Ulas UH, Ozogul C, Timurkaynak E,. 2003. Effect of mannitol in experimental spinal cord injury: An ultrastructural and electrophysiological study. Neurol India 51: 350-354.
8. Bethea JR, Dietrich WD,. 2002. Targeting the host inflammatory response in traumatic spinal cord injury. Curr Opin Neurol 15: 355-360.
9. Bethea JR, Castro M, Keane RW, Lee TT, Dietrich WD, Yezierski RP,. 1998. Traumatic spinal cord injury induces nuclear factor-kappaB activation. J Neurosci 18: 3251-3260.
10. Bomstein Y, Marder JB, Vitner K, Smirnov I, Lisaey G, Butovsky O, Fulga V, Yoles E,. 2003. Features of skin-coincubated macrophages that promote recovery from spinal cord injury. J Neuroimmunol 142: 10-16.
11. Carlson GD, Warden KE, Barbeau JM, Bahniuk E, Kutina-Nelson KL, Biro CL, Bohlman HH, LaManna JC,. 1997. Viscoelastic relaxation and regional blood flow response to spinal cord compression and decompression. Spine (Phila Pa 1976) 22: 1285-1291.
12. Carlson GD, Gorden CD, Oliff HS, Pillai JJ, LaManna JC,. 2003. Sustained spinal cord compression: Part I: Time-dependent effect on long-term pathophysiology. J Bone Joint Surg Am 85-A: 86-94.
13. Center NSCIS. June 15, 2011. Spinal Cord Injury Facts and Figures at a Glance. Birmingham: The University of Alabama at Birmingham.
14. Chapman JR, Anderson PA,. 1994. Thoracolumbar spine fractures with neurologic deficit. Orthop Clin North Am 25: 595-612.
15. Choi DW,. 1988. Calcium-mediated neurotoxicity: Relationship to specific channel types and role in ischemic damage. Trends Neurosci 11: 465-469.
16. Choi DW, Rothman SM,. 1990. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu Rev Neurosci 13: 171-182.
17. Choi DW, Koh JY, Peters S,. 1988. Pharmacology of glutamate neurotoxicity in cortical cell culture: Attenuation by NMDA antagonists. J Neurosci 8: 185-196.
18. Cohen IR, Schwartz M,. 1999. Autoimmune maintenance and neuroprotection of the central nervous system. J Neuroimmunol 100: 111-114.
19. David S, Bouchard C, Tsatas O, Giftochristos N,. 1990. Macrophages can modify the nonpermissive nature of the adult mammalian central nervous system. Neuron 5: 463-469.
20. David S, Zarruk JG, Ghasemlou N,. 2012. Inflammatory pathways in spinal cord injury. Int Rev Neurobiol 106: 127-152.
21. Delamarter RB, Sherman J, Carr JB,. 1995. Pathophysiology of spinal cord injury. Recovery after immediate and delayed decompression. J Bone Joint Surg Am 77: 1042-1049.
22. Dolan EJ, Tator CH, Endrenyi L,. 1980a. The value of decompression for acute experimental spinal cord compression injury. J Neurosurg 53: 749-755.
23. Dolan EJ, Transfeldt EE, Tator CH, Simmons EH, Hughes KF,. 1980b. The effect of spinal distraction on regional spinal cord blood flow in cats. J Neurosurg 53: 756-764.
24. Donnelly DJ, Popovich PG,. 2008. Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp Neurol 209: 378-388.
25. Ducker TB, Salcman M, Daniell HB,. 1978. Experimental spinal cord trauma, III: Therapeutic effect of immobilization and pharmacologic agents. Surg Neurol 10: 71-76.
26. Fan LH, Wang KZ, Cheng B,. 2006. [Protective effects of ginkgo leaf extracts on neurons in spinal cord after ischemia-reperfusion injury in rabbits]. Zhong Xi Yi Jie He Xue Bao 4: 181-184.
27. Farooque M, Hillered L, Holtz A, Olsson Y,. 1996. Changes of extracellular levels of amino acids after graded compression trauma to the spinal cord: An experimental study in the rat using microdialysis. J Neurotrauma 13: 537-548.
28. Fee D, Crumbaugh A, Jacques T, Herdrich B, Sewell D, Auerbach D, Piaskowski S, Hart MN, Sandor M, Fabry Z,. 2003. Activated/effector CD4+ T cells exacerbate acute damage in the central nervous system following traumatic injury. J Neuroimmunol 136: 54-66.
29. Fitch W, MacKenzie ET, Harper AM,. 1975. Effects of decreasing arterial blood pressure on cerebral blood flow in the baboon. Influence of the sympathetic nervous system. Circ Res 37: 550-557.
30. Fleming JC, Norenberg MD, Ramsay DA, Dekaban GA, Marcillo AE, Saenz AD, Pasquale-Styles M, Dietrich WD, Weaver LC,. 2006. The cellular inflammatory response in human spinal cords after injury. Brain 129: 3249-3269.
31. Friedmann I, Hauben E, Yoles E, Kardash L, Schwartz M,. 2001. T cell-mediated neuroprotection involves antithrombin activity. J Neuroimmunol 121: 12-21.
32. Greenamyre JT, Porter RH,. 1994. Anatomy and physiology of glutamate in the CNS. Neurology 44: S7-S13.
33. Griessenauer CJ, Raborn J, Foreman P, Shoja MM, Loukas M, Tubbs RS,. 2014. Venous drainage of the spine and spinal cord: A comprehensive review of its history, embryology, anatomy, physiology, and pathology. Clin Anat, in press.
34. Griffiths IR, Pitts LH, Crawford RA, Trench JG,. 1978. Spinal cord compression and blood flow. I. The effect of raised cerebrospinal fluid pressure on spinal cord blood flow. Neurology 28: 1145-1151.
35. Haggendal E, Lofgren J, Nilsson NJ, Zwetnow NN,. 1970. Effects of varied cerebrospinal fluid pressure on cerebral blood flow in dogs. Acta Physiol Scand 79: 262-271.
36. Hall ED,. 1993. The role of oxygen radicals in traumatic injury: Clinical implications. J Emerg Med 11: 31-36.
37. Hall ED, Wolf DL,. 1986. A pharmacological analysis of the pathophysiological mechanisms of posttraumatic spinal cord ischemia. J Neurosurg 64: 951-961.
38. Hauben E, Butovsky O, Nevo U, Yoles E, Moalem G, Agranov E, Mor F, Leibowitz-Amit R, Pevsner E, Akselrod S, Neeman M, Cohen IR, Schwartz M,. 2000a. Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion. J Neurosci 20: 6421-6430.
39. Hauben E, Nevo U, Yoles E, Moalem G, Agranov E, Mor F, Akselrod S, Neeman M, Cohen IR, Schwartz M,. 2000b. Autoimmune T cells as potential neuroprotective therapy for spinal cord injury. Lancet 355: 286-287.
40. Hauben E, Gothilf A, Cohen A, Butovsky O, Nevo U, Smirnov I, Yoles E, Akselrod S, Schwartz M,. 2003. Vaccination with dendritic cells pulsed with peptides of myelin basic protein promotes functional recovery from spinal cord injury. J Neurosci 23: 8808-8819.
41. Hayes KC, Hull TC, Delaney GA, Potter PJ, Sequeira KA, Campbell K, Popovich PG,. 2002. Elevated serum titers of proinflammatory cytokines and CNS autoantibodies in patients with chronic spinal cord injury. J Neurotrauma 19: 753-761.
42. Hitchon PW, Dyste GN, Osenbach RK, Todd MM, Yamada T, Jensen AE,. 1990. Spinal cord blood flow in response to focal compression. J Spinal Disord 3: 210-219.
43. Hsu CY, Halushka PV, Hogan EL, Banik NL, Lee WA, Perot PL, Jr,. 1985. Alteration of thromboxane and prostacyclin levels in experimental spinal cord injury. Neurology 35: 1003-1009.
44. Ibarra A, Martinez S, Reyes J, Meza-Lucas A, Mandujano A, Grijalva I, Madrazo I, Correa D,. 2000. Search for an IgG response against neural antigens in experimental spinal cord injury. Neuroscience 96: 3-5.
45. Ilhan A, Yilmaz HR, Armutcu F, Gurel A, Akyol O,. 2004. The protective effect of nebivolol on ischemia/reperfusion injury in rabbit spinal cord. Prog Neuropsychopharmacol Biol Psychiatry 28: 1153-1160.
46. Ishizaki M, Sugiyama S, Uchida H, Nawa S, Shimizu N,. 1997. Intrathecal oxygen concentration as a new indicator of spinal cord ischemia. Acta Med Okayama 51: 71-77.
47. Jakovcevic D, Harder DR,. 2007. Role of astrocytes in matching blood flow to neuronal activity. Curr Top Dev Biol 79: 75-97.
48. Jellinger K,. 1972. Circulation disorders of the spinal cord. Acta Neurochir 26: 327-337.
49. Jones TB, Basso DM, Sodhi A, Pan JZ, Hart RP, MacCallum RC, Lee S, Whitacre CC, Popovich PG,. 2002. Pathological CNS autoimmune disease triggered by traumatic spinal cord injury: Implications for autoimmune vaccine therapy. J Neurosci 22: 2690-2700.
50. Katoh D, Ikata T, Katoh S, Hamada Y, Fukuzawa K,. 1996. Effect of dietary vitamin C on compression injury of the spinal cord in a rat mutant unable to synthesize ascorbic acid and its correlation with that of vitamin E. Spinal Cord 34: 234-238.
51. Kawaja MD, Gage FH,. 1991. Reactive astrocytes are substrates for the growth of adult CNS axons in the presence of elevated levels of nerve growth factor. Neuron 7: 1019-1030.
52. Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, Popovich PG,. 2009. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci 29: 13435-13444.
53. Kil K, Zang YC, Yang D, Markowski J, Fuoco GS, Vendetti GC, Rivera VM, Zhang JZ,. 1999. T cell responses to myelin basic protein in patients with spinal cord injury and multiple sclerosis. J Neuroimmunol 98: 201-207.
54. Kinuta Y, Kimura M, Itokawa Y, Ishikawa M, Kikuchi H,. 1989. Changes in xanthine oxidase in ischemic rat brain. J Neurosurg 71: 417-420.
55. Koyanagi I, Tator CH, Lea PJ,. 1993. Three-dimensional analysis of the vascular system in the rat spinal cord with scanning electron microscopy of vascular corrosion casts. Part 2: Acute spinal cord injury. Neurosurgery 33: 285-291; discussion 292.
56. Lagord C, Berry M, Logan A,. 2002. Expression of TGFbeta2 but not TGFbeta1 correlates with the deposition of scar tissue in the lesioned spinal cord. Mol Cell Neurosci 20: 69-92.
57. Laschinger JC, Cunningham JN, Jr, Nathan IM, Knopp EA, Cooper MM, Spencer FC,. 1983. Experimental and clinical assessment of the adequacy of partial bypass in maintenance of spinal cord blood flow during operations on the thoracic aorta. Ann Thorac Surg 36: 417-426.
58. Lewen A, Matz P, Chan PH,. 2000. Free radical pathways in CNS injury. J Neurotrauma 17: 871-890.
59. Lipton SA, Rosenberg PA,. 1994. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 330: 613-622.
60. Maeda S, Miyamoto T, Murata H, Yamashita K,. 1989. Prevention of spinal cord ischemia by monitoring spinal cord perfusion pressure and somatosensory evoked potentials. J Cardiovasc Surg 30: 565-571.
61. McTigue DM, Popovich PG, Morgan TE, Stokes BT,. 2000. Localization of transforming growth factor-beta1 and receptor mRNA after experimental spinal cord injury. Exp Neurol 163: 220-230.
62. Merrill JE, Zimmerman RP,. 1991. Natural and induced cytotoxicity of oligodendrocytes by microglia is inhibitable by TGF beta. Glia 4: 327-331.
63. Mitchell CS, Lee RH,. 2008. Pathology dynamics predict spinal cord injury therapeutic success. J Neurotrauma 25: 1483-1497.
64. Mizrachi Y, Ohry A, Aviel A, Rozin R, Brooks ME, Schwartz M,. 1983. Systemic humoral factors participating in the course of spinal cord injury. Paraplegia 21: 287-293.
65. Morin-Richaud C, Feldblum S, Privat A,. 1998. Astrocytes and oligodendrocytes reactions after a total section of the rat spinal cord. Brain Res 783: 85-101.
66. Noble LJ, Wrathall JR,. 1989. Distribution and time course of protein extravasation in the rat spinal cord after contusive injury. Brain Res 482: 57-66.
67. Norenberg MD, Smith J, Marcillo A,. 2004. The pathology of human spinal cord injury: Defining the problems. J Neurotrauma 21: 429-440.
68. Pan JZ, Ni L, Sodhi A, Aguanno A, Young W, Hart RP,. 2002. Cytokine activity contributes to induction of inflammatory cytokine mRNAs in spinal cord following contusion. J Neurosci Res 68: 315-322.
69. Piani D, Frei K, Pfister HW, Fontana A,. 1993. Glutamate uptake by astrocytes is inhibited by reactive oxygen intermediates but not by other macrophage-derived molecules including cytokines, leukotrienes or platelet-activating factor. J Neuroimmunol 48: 99-104.
70. Pineau I, Lacroix S,. 2007. Proinflammatory cytokine synthesis in the injured mouse spinal cord: Multiphasic expression pattern and identification of the cell types involved. J Comp Neurol 500: 267-285.
71. Pineau I, Sun L, Bastien D, Lacroix S,. 2010. Astrocytes initiate inflammation in the injured mouse spinal cord by promoting the entry of neutrophils and inflammatory monocytes in an IL-1 receptor/MyD88-dependent fashion. Brain Behav Immun 24: 540-553.
72. Pitt D, Nagelmeier IE, Wilson HC, Raine CS,. 2003. Glutamate uptake by oligodendrocytes: Implications for excitotoxicity in multiple sclerosis. Neurology 61: 1113-1120.
73. Popovich PG, Stokes BT, Whitacre CC,. 1996. Concept of autoimmunity following spinal cord injury: Possible roles for T lymphocytes in the traumatized central nervous system. J Neurosci Res 45: 349-363.
74. Popovich PG, Wei P, Stokes BT,. 1997. Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J Comp Neurol 377: 443-464.
75. Qiao F, Atkinson C, Song H, Pannu R, Singh I, Tomlinson S,. 2006. Complement plays an important role in spinal cord injury and represents a therapeutic target for improving recovery following trauma. Am J Pathol 169: 1039-1047.
76. Reed JE, Allen WE, 3rd, Dohrmann GJ,. 1979. Effect of mannitol on the traumatized spinal cord. Microangiography, blood flow patterns, and electrophysiology. Spine (Phila Pa 1976) 4: 391-397.
77. Rice T, Larsen J, Rivest S, Yong VW,. 2007. Characterization of the early neuroinflammation after spinal cord injury in mice. J Neuropathol Exp Neurol 66: 184-195.
78. Rimaniol AC, Haik S, Martin M, Le Grand R, Boussin FD, Dereuddre-Bosquet N, Gras G, Dormont D,. 2000. Na+-dependent high-affinity glutamate transport in macrophages. J Immunol 164: 5430-5438.
79. Rothman SM, Olney JW,. 1986. Glutamate and the pathophysiology of hypoxic-Ischemic brain damage. Ann Neurol 19: 105-111.
80. Sandler AN, Tator CH,. 1976a. Effect of acute spinal cord compression injury on regional spinal cord blood flow in primates. J Neurosurg 45: 660-676.
81. Sandler AN, Tator CH,. 1976b. Review of the effect of spinal cord trama on the vessels and blood flow in the spinal cord. J Neurosurg 45: 638-646.
82. Schroeter M, Jander S,. 2005. T-cell cytokines in injury-induced neural damage and repair. Neuromolecular Med 7: 183-195.
83. Schwab ME, Bartholdi D,. 1996. Degeneration and regeneration of axons in the lesioned spinal cord. Physiol Rev 76: 319-370.
84. Schwab ME, Caroni P,. 1988. Oligodendrocytes and CNS myelin are nonpermissive substrates for neurite growth and fibroblast spreading in vitro. J Neurosci 8: 2381-2393.
85. Schwartz M, Yoles E,. 2006. Immune-based therapy for spinal cord repair: Autologous macrophages and beyond. J Neurotrauma 23: 360-370.
86. Schwartz M, Cohen I, Lazarov-Spiegler O, Moalem G, Yoles E,. 1999. The remedy may lie in ourselves: Prospects for immune cell therapy in central nervous system protection and repair. J Mol Med 77: 713-717.
87. Senter HJ, Venes JL,. 1979. Loss of autoregulation and posttraumatic ischemia following experimental spinal cord trauma. J Neurosurg 50: 198-206.
88. Shechter R, London A, Varol C, Raposo C, Cusimano M, Yovel G, Rolls A, Mack M, Pluchino S, Martino G, Jung S, Schwartz M,. 2009. Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice. PLoS Med 6: e1000113.
89. Shi E, Jiang X, Kazui T, Washiyama N, Yamashita K, Terada H, Bashar AH,. 2007. Controlled low-pressure perfusion at the beginning of reperfusion attenuates neurologic injury after spinal cord ischemia. J Thorac Cardiovasc Surg 133: 942-948.
90. Siesjo BK,. 1988. Historical overview. Calcium, ischemia, and death of brain cells. Ann N Y Acad Sci 522: 638-661.
91. Singh P, Agarwal N, Barrese J, Heary R,. 2012. Current therapeutic strategies for inflammation following traumatic spinal cord injury. Neural Regen Res 7: 1812-1821.
92. Sroga JM, Jones TB, Kigerl KA, McGaughy VM, Popovich PG,. 2003. Rats and mice exhibit distinct inflammatory reactions after spinal cord injury. J Comp Neurol 462: 223-240.
93. Stirling DP, Yong VW,. 2008. Dynamics of the inflammatory response after murine spinal cord injury revealed by flow cytometry. J Neurosci Res 86: 1944-1958.
94. Streit WJ, Semple-Rowland SL, Hurley SD, Miller RC, Popovich PG, Stokes BT,. 1998. Cytokine mRNA profiles in contused spinal cord and axotomized facial nucleus suggest a beneficial role for inflammation and gliosis. Exp Neurol 152: 74-87.
95. Takahashi JL, Giuliani F, Power C, Imai Y, Yong VW,. 2003. Interleukin-1beta promotes oligodendrocyte death through glutamate excitotoxicity. Ann Neurol 53: 588-595.
96. Taoka Y, Okajima K, Uchiba M, Murakami K, Kushimoto S, Johno M, Naruo M, Okabe H, Takatsuki K,. 1997. Role of neutrophils in spinal cord injury in the rat. Neuroscience 79: 1177-1182.
97. Tarlov I,. 1957. Spinal Cord Compression: Mechanisms of Paralysis and Treatment. Springfield, IL: Thomas.
98. Tator CH,. 1991. Review of experimental spinal cord injury with emphasis on the local and systemic circulatory effects. Neurochirurgie 37: 291-302.
99. Tator CH, Fehlings MG,. 1991. Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J Neurosurg 75: 15-26.
100. Tator CH, Koyanagi I,. 1997. Vascular mechanisms in the pathophysiology of human spinal cord injury. J Neurosurg 86: 483-492.
101. Tymianski M, Tator CH,. 1996. Normal and abnormal calcium homeostasis in neurons: A basis for the pathophysiology of traumatic and ischemic central nervous system injury. Neurosurgery 38: 1176-1195.
102. van Landeghem FK, Stover JF, Bechmann I, Bruck W, Unterberg A, Buhrer C, von Deimling A,. 2001. Early expression of glutamate transporter proteins in ramified microglia after controlled cortical impact injury in the rat. Glia 35: 167-179.
103. Volterra A, Trotti D, Tromba C, Floridi S, Racagni G,. 1994. Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes. J Neurosci 14: 2924-2932.
104. Whetstone WD, Hsu JY, Eisenberg M, Werb Z, Noble-Haeusslein LJ,. 2003. Blood-spinal cord barrier after spinal cord injury: Relation to revascularization and wound healing. J Neurosci Res 74: 227-239.
105. Wrathall JR, Teng YD, Choiniere D,. 1996. Amelioration of functional deficits from spinal cord trauma with systemically administered NBQX, an antagonist of non-N-methyl-D-aspartate receptors. Exp Neurol 137: 119-126.
106. Wu D, Miyamoto O, Shibuya S, Okada M, Igawa H, Janjua NA, Norimatsu H, Itano T,. 2005. Different expression of macrophages and microglia in rat spinal cord contusion injury model at morphological and regional levels. Acta Med Okayama 59: 121-127.
107. Yamamoto M, Meyer JS, Sakai F, Jakoby R,. 1980. Effect of differential spinal cord transection on human cerebral blood flow. J Neurol Sci 47: 395-406.
108. Yang L, Blumbergs PC, Jones NR, Manavis J, Sarvestani GT, Ghabriel MN,. 2004. Early expression and cellular localization of proinflammatory cytokines interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in human traumatic spinal cord injury. Spine (Phila Pa 1976) 29: 966-971.
109. Yang L, Jones NR, Blumbergs PC, Van Den Heuvel C, Moore EJ, Manavis J, Sarvestani GT, Ghabriel MN,. 2005. Severity-dependent expression of pro-inflammatory cytokines in traumatic spinal cord injury in the rat. J Clin Neurosci 12: 276-284.
110. Young W,. 1993. Secondary injury mechanisms in acute spinal cord injury. J Emerg Med 11: 13-22.
111. Zerangue N, Arriza JL, Amara SG, Kavanaugh MP,. 1995. Differential modulation of human glutamate transporter subtypes by arachidonic acid. J Biol Chem 270: 6433-6435.
112. Ziv Y, Avidan H, Pluchino S, Martino G, Schwartz M,. 2006. Synergy between immune cells and adult neural stem/progenitor cells promotes functional recovery from spinal cord injury. Proc Natl Acad Sci USA 103: 13174-13179.